Sequencing Endocrine Therapy and Targeted Agents for the Treatment of Metastatic HR+/HER2- Breast Cancer
Noridza Rodriguez-Rivera, MD
The Challenges of Biosimilars in the Daily Oncology Practice?
Dina B. Dumercy McHenry, PharmD, MBA, BCOP
Treating Advanced Or Metastatic Cervical Cancer ADCs, VEGF Inhibitors, And Immunotherapy
Don S. Dizon, MD, FACP, FASCO
Controversies In The Management Of Ovarian Cancer A Focus On First Line Treatment
Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS
Advances in the Treatment of High Risk Early Stage Hormone Receptor Positive Breast Cancer
William J. Gradishar, MD, FASCO, FACP
